 <h1>Elotuzumab Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> fever.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to elotuzumab: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, elotuzumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking elotuzumab:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>body aches or pain</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>confusion</li>
<li>cough</li>
<li>dark urine</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>loss of appetite</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>nasal congestion</li>
<li>nausea</li>
<li>nervousness</li>
<li>painful or difficult urination</li>
<li>persistent sore that does not heal</li>
<li>pink skin growth</li>
<li>pounding in the ears</li>
<li>reddish patch or irritated area</li>
<li>redness of the skin</li>
<li>runny nose</li>
<li>shiny skin bump</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach pain or tenderness</li>
<li>stuffy nose</li>
<li>sweating</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>troubled breathing or swallowing</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>white, yellow or waxy scar-like area on the skin</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>anxiety</li>
<li>decreased awareness or responsiveness</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dizziness or lightheadedness</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>hostility</li>
<li>irritability</li>
<li>loss of consciousness</li>
<li>muscle twitching</li>
<li>pale skin</li>
<li>rapid weight gain</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of elotuzumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blindness</li>
<li>burning, numbness, tingling, or painful sensations</li>
<li>decreased appetite</li>
<li>decreased vision</li>
<li>decreased weight</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement</li>
<li>muscle aches</li>
<li>night sweats</li>
<li>pain in the arms or legs</li>
<li>unsteadiness or awkwardness</li>
<li>weakness in the arms, hands, legs, or feet</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to elotuzumab: intravenous powder for injection</i></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Night sweats<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (47%), constipation (36%), vomiting (15%), oropharyngeal pain (10%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia (13%)</p>
<p><b>Frequency not reported</b>: Leukopenia, thrombocytopenia, deep vein thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hypoalbuminemia, elevated alkaline phosphatase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p>
<p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (21%), weight loss (14%)</p>
<p><b>Frequency not reported</b>: Hyperglycemia, hypocalcemia, low bicarbonate, hyperkalemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremities (16%)</p>
<p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (27%), headache (15%)</p>
<p><b>Common</b> (1% to 10%): Hypoesthesia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts (12%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Invasive second primary malignancies (SPM)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (62%), pyrexia (37%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Altered mood<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (34%), nasopharyngitis (25%), upper respiratory tract infection (23%), pneumonia (20%)</p>
<p><b>Common</b> (1% to 10%): Respiratory tract infection, pulmonary embolism<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Herpes zoster<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Empliciti (elotuzumab)." Bristol-Myers Squibb, Princeton, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is Empliciti (elotuzumab)? and how does Empliciti work?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about elotuzumab</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Elotuzumab Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Empliciti</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Myeloma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to elotuzumab: intravenous powder for injection</i></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Night sweats<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (47%), constipation (36%), vomiting (15%), oropharyngeal pain (10%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia (13%)</p><p><b>Frequency not reported</b>: Leukopenia, thrombocytopenia, deep vein thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hypoalbuminemia, elevated alkaline phosphatase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (21%), weight loss (14%)</p><p><b>Frequency not reported</b>: Hyperglycemia, hypocalcemia, low bicarbonate, hyperkalemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremities (16%)</p><p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (27%), headache (15%)</p><p><b>Common</b> (1% to 10%): Hypoesthesia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts (12%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Invasive second primary malignancies (SPM)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (62%), pyrexia (37%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Altered mood<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (34%), nasopharyngitis (25%), upper respiratory tract infection (23%), pneumonia (20%)</p><p><b>Common</b> (1% to 10%): Respiratory tract infection, pulmonary embolism<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Herpes zoster<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Empliciti (elotuzumab)." Bristol-Myers Squibb, Princeton, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is Empliciti (elotuzumab)? and how does Empliciti work?</li>
</ul><h2>More about elotuzumab</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Elotuzumab Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Myeloma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>